Sort
21,453 grants matching “tuberculosis”
The impact of alcohol consumption on TB treatment outcomes
$672,957Karen R Jacobson · Boston Medical Center · R01 · FY2020 · AI
Latent and Reactivation Tuberculosis
$672,911University Of Pittsburgh At Pittsburgh · R01 · FY2003 · HL
The roles of genes critical for growth under defined conditions in vitro or duri
$672,898Eric Joseph Rubin · Harvard School Of Public Health · U19 · FY2015 · AI
A TB Vaccine for AIDS Patients
$672,892Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2009 · AI
Patient reported outcomes in patients with nontuberculous mycobacterial pulmonary disease
$672,815Emily M. Henkle · Oregon Health & Science University · R01 · FY2023 · HL
Targeted cell-depleting immunotherapy for TB and HIV
$672,796William Ramses Bishai · Johns Hopkins University · R01 · FY2022 · AI
Targeted cell-depleting immunotherapy for TB and HIV
$672,796William Ramses Bishai · Johns Hopkins University · R01 · FY2023 · AI
Targeted cell-depleting immunotherapy for TB and HIV
$672,796William Ramses Bishai · Johns Hopkins University · R01 · FY2020 · AI
Targeted cell-depleting immunotherapy for TB and HIV
$672,796William Ramses Bishai · Johns Hopkins University · R01 · FY2021 · AI
Targeted cell-depleting immunotherapy for TB and HIV
$672,796William Ramses Bishai · Johns Hopkins University · R01 · FY2024 · AI
MITIGATION OF EPISODIC WASTING IN HIV INFECTION
$672,717University Of California San Francisco · R01 · FY2000 · DK
PROJECT 2: Determine clinically relevant host-viral dependency networks for respiratory infections including SARS-CoV-2
$672,529Melanie Maria Ott · University Of California, San Francisco · U19 · FY2023 · AI
Lung Resident, MR1-Restricted T Cells: Association with Differential Outcomes Following Exposure to M. Tuberculosis
$672,512David M. Lewinsohn · Oregon Health & Science University · R01 · FY2022 · AI
Anti-TB sterilizing immunity in immune and HIV+ individuals
$672,467Zheng W Chen · University Of Illinois At Chicago · R01 · FY2018 · HL
TB/HIV RISK REDUCTION WITH HOMELESS AND DRUG ADDICTED
$672,463University Of California Los Angeles · R01 · FY2001 · DA
Novel Biomarkers to Shorten TB Treatment
$672,409David Alland · Rbhs-New Jersey Medical School · R01 · FY2016 · AI
Linking Human TB Genetic Susceptibility Loci to Granuloma Biology
$671,827David M. Tobin · Duke University · R01 · FY2025 · AI
Predicting neurodevelopmental risk in children born to mothers living with HIV in Kenya
$671,758Megan Song McHenry · Indiana University Indianapolis · R01 · FY2021 · HD
Optimizing HIV Care in Less Developed Countries
$671,718Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2006 · AI
BIODIVERSITY CONSERVATION &DRUG DISCOVERY IN MADAGASCAR
$671,468Virginia Polytechnic Inst And St Univ · U01 · FY2003 · TW
Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring
$671,340Anna M Mandalakas · Baylor College Of Medicine · R01 · FY2019 · AI
Studies of the Antibacterial Activity of and Resistance to Molecules Targeting the ClpP Peptidase
$671,303Jason K Sello · Brown University · R01 · FY2017 · AI
A Nurse Case Management Intervention to Improve MDR-TB/HIV Coinfection Outcomes
$671,273Jason Edward Farley · Johns Hopkins University · R01 · FY2014 · AI
Identifying Common T Cell Responses to Major Pathogens in Rhesus Macaques
$671,125David H Oconnor · University Of Wisconsin-Madison · R24 · FY2017 · OD
Identifying Common T Cell Responses to Major Pathogens in Rhesus Macaques
$671,125David H Oconnor · University Of Wisconsin-Madison · R24 · FY2016 · OD